Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXDXNASDAQ:BNGONASDAQ:HLTHNASDAQ:SEER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22509,433 shs53.64 million shsBNGOBionano Genomics$3.32+1.8%$3.86$2.68▼$52.20$11.17M2.27108,167 shs74,848 shsHLTHCue Health$0.04-29.8%$0.07$0.04▼$0.74$6.91M1.0913.38 million shs96.00 million shsSEERSeer$1.98+1.0%$2.03$1.56▼$2.63$116.56M1.54328,830 shs160,059 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXDXAccelerate Diagnostics0.00%0.00%0.00%-96.42%-96.51%BNGOBionano Genomics+1.84%-9.54%-11.23%+2.15%-92.86%HLTHCue Health0.00%0.00%0.00%0.00%0.00%SEERSeer+1.02%-9.59%-4.35%+4.21%+18.56%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXDXAccelerate Diagnostics0.9467 of 5 stars0.00.00.04.70.02.50.6BNGOBionano Genomics0.9778 of 5 stars3.11.00.00.00.60.00.6HLTHCue HealthN/AN/AN/AN/AN/AN/AN/AN/ASEERSeer2.7352 of 5 stars3.03.00.00.02.53.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/ABNGOBionano Genomics 2.25Hold$7.00110.84% UpsideHLTHCue Health 0.00N/AN/AN/ASEERSeer 2.00Hold$3.0051.52% UpsideCurrent Analyst Ratings BreakdownLatest SEER, AXDX, BNGO, and HLTH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/9/2025BNGOBionano GenomicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.004/2/2025BNGOBionano GenomicsScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$1.00 ➝ $4.00(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00BNGOBionano Genomics$30.78M0.36N/AN/A$18.12 per share0.18HLTHCue Health$70.94M0.10N/AN/A$1.62 per share0.03SEERSeer$14.17M8.23N/AN/A$5.54 per share0.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/ABNGOBionano Genomics-$112.02M-$138.92N/A∞N/A-294.05%-125.75%-71.96%8/6/2025 (Estimated)HLTHCue Health-$373.46M-$2.44N/AN/AN/A-526.48%-67.82%-53.79%N/ASEERSeer-$86.60M-$1.41N/AN/AN/A-560.90%-24.69%-22.13%8/6/2025 (Estimated)Latest SEER, AXDX, BNGO, and HLTH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BNGOBionano Genomics-$3.49-$1.15+$2.34-$1.15$6.25 million$6.46 million5/13/2025Q1 2025SEERSeer-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million3/20/2025Q4 2024AXDXAccelerate Diagnostics-$0.50-$0.37+$0.13-$0.37$3.00 million$2.82 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/ABNGOBionano GenomicsN/AN/AN/AN/AN/AHLTHCue HealthN/AN/AN/AN/AN/ASEERSeerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXDXAccelerate DiagnosticsN/A1.501.34BNGOBionano Genomics0.071.701.34HLTHCue HealthN/A2.542.22SEERSeerN/A19.3418.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXDXAccelerate Diagnostics17.14%BNGOBionano Genomics11.35%HLTHCue Health45.49%SEERSeer75.20%Insider OwnershipCompanyInsider OwnershipAXDXAccelerate Diagnostics43.60%BNGOBionano Genomics0.90%HLTHCue Health12.50%SEERSeer11.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableBNGOBionano Genomics3003.36 million3.33 millionOptionableHLTHCue Health726159.09 million139.21 millionOptionableSEERSeer16058.87 million52.23 millionOptionableSEER, AXDX, BNGO, and HLTH HeadlinesRecent News About These CompaniesKarnataka seer says free travel scheme raising mutts' visitors food burdenJune 19 at 10:27 AM | msn.comKarnataka Minister Backs Guarantees After Seer’s Remarks, Rules Out Longer Work Hours ClaimJune 19 at 5:27 AM | msn.comAP: Protect Vedas, save ancient tradition and culture: Udupi Sirur Mutt SeerJune 18 at 10:45 PM | uniindia.comBaba Vanga's chilling WW3 predictionJune 18 at 10:45 PM | msn.comBaba Vanga reveals: 4 zodiac signs will become extremely wealthy by the end of 2025June 18 at 5:45 PM | msn.comSiddaramaiah's guarantee schemes a burden on mutts: SeerJune 18 at 12:46 AM | msn.comCRC Outcomes Better When First of Multiple CancersJune 17 at 7:45 PM | medscape.comInsider Selling: Seer, Inc. (NASDAQ:SEER) Director Sells 30,253 Shares of StockJune 17 at 5:04 AM | insidertrades.comSeer, Inc. (NASDAQ:SEER) Director Dipchand Nishar Sells 30,253 SharesJune 16 at 8:51 PM | marketbeat.comWhere To Find The Seer In Tainted Grail: The Fall Of AvalonJune 13, 2025 | msn.comBright The Seer releases prophecy, sends powerful warning message to Tinubu, watch full videoJune 11, 2025 | msn.comRare cancer diagnoses surge dramatically among millennials, Gen XJune 11, 2025 | msn.comThe SEER Group Expands Northwest Presence With Acquisition of Oregon’s Associated Heating & Air ConditioningJune 10, 2025 | joplinglobe.comKalkine : Top NASDAQ Companies by Market Cap Featuring Seer IncJune 10, 2025 | kalkinemedia.comBright The Seer releases prophecy, reveals “anointed person to win 2027 presidential election”, watch full videoJune 10, 2025 | msn.comWhat Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?June 10, 2025 | zacks.comSeer takes the lead in Miyawaki model forest developmentJune 10, 2025 | timesofindia.indiatimes.comVerydarkman slams Bright the Seer as she prophecies that Wizkid, Tinubu and Wike should see herJune 9, 2025 | msn.comAl Seer Marine's 'Lucky Gas' VLGC sets sailJune 8, 2025 | wam.aeSurgical Outcomes in OAs With Colorectal CancerJune 8, 2025 | physiciansweekly.comOtto Aviation: Unlocking Aerospace Innovation with Galoraths SEER PlatformJune 4, 2025 | eurekamagazine.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSEER, AXDX, BNGO, and HLTH Company DescriptionsAccelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.Bionano Genomics NASDAQ:BNGO$3.32 +0.06 (+1.84%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$3.28 -0.04 (-1.20%) As of 06/18/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.Cue Health NASDAQ:HLTHCue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.Seer NASDAQ:SEER$1.98 +0.02 (+1.02%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$1.98 +0.01 (+0.25%) As of 06/18/2025 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
